Abbott Laboratories (ABT) key performance indicators and operating metrics (22 metrics) from SEC EDGAR filings, earnings calls, and investor decks. First-party data.
| Metric | Latest Value | Period |
|---|---|---|
| Diluted Earnings Per Share (Adjusted) | 1.31 USD_per_share | FY2026-Q2 |
| Established Pharmaceuticals Sales | 1.43B | FY2026-Q1 |
| Nutrition Sales | 2.02B | FY2026-Q1 |
| Core Laboratory Diagnostics Sales | 1.27B | FY2026-Q1 |
| Diagnostics Sales International | 1.28B | FY2026-Q1 |
| Nutrition Sales International | 1.17B | FY2026-Q1 |
| Diagnostics Sales in the United States | 905M | FY2026-Q1 |
| Nutrition Sales in the United States | 844M | FY2026-Q1 |
| Net Earnings (GAAP) | 1.08B | FY2026-Q1 |
| Diagnostics Sales | 2.46B | FY2025-Q4 |
| Nutrition Adult Sales | 343M | FY2025-Q4 |
| Nutrition Pediatric Sales | 463M | FY2025-Q4 |
| Total Sales | 11.46B | FY2025-Q4 |
| Rapid Diagnostics Sales | 697M | FY2025-Q4 |
Back to ABT overview · ABT earnings · ABT holders
Data sourced from U.S. SEC EDGAR filings, earnings call transcripts, and investor decks. Not personalized investment advice.